Pharmacokinetics during therapeutic hypothermia in neonates: from pathophysiology to translational knowledge and physiologically-based pharmacokinetic (PBPK) modeling

References

• Davidson JO, Gonzalez F, Gressens P, et al. Update on mechanisms of the pathophysiology of neonatal encephalopathy. Semin Fetal Neonatal Med. 2021 Oct;26(5):101267.
   PubMed Web of Science ®Google Scholar
• WHO. Levels and trends in child mortality report, News Room, Fact-sheets2021 [cited 2023 May 5]. Fact-sheets2021 https://www.who.int/news-room/fact-sheets/detail/levels-and-trends-in-child-mortality-report-2021
   Google Scholar
• Michniewicz B, Szpecht D, Sowińska A, et al. Biomarkers in newborns with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia. Childs Nerv Syst. 2020 Dec;36(12):2981–2988.
   PubMed Web of Science ®Google Scholar
• Abate BB, Bimerew M, Gebremichael B, et al. Effects of therapeutic hypothermia on death among asphyxiated neonates with hypoxic-ischemic encephalopathy: A systematic review and meta-analysis of randomized control trials. Plos One. 2021;16(2):e0247229. doi: 10.1371/journal.pone.0247229
   PubMed Web of Science ®Google Scholar
• Sun YJ, Zhang ZY, Fan B, et al. Neuroprotection by Therapeutic Hypothermia. Front Neurosci. 2019;13:586. doi: 10.3389/fnins.2019.00586
   PubMed Web of Science ®Google Scholar
• O’Dea M, Sweetman D, Bonifacio SL, et al. Management of multi organ dysfunction in neonatal encephalopathy. Front Pediatr. 2020;8:239. doi: 10.3389/fped.2020.00239
   PubMed Web of Science ®Google Scholar
• Nestaas E, Walsh BH. Hypothermia and Cardiovascular Instability. Clin Perinatol. 2020 Sep;47(3):575–592. doi: 10.1016/j.clp.2020.05.012
   PubMed Web of Science ®Google Scholar
• Nestaas E, Skranes JH, Støylen A, et al. The myocardial function during and after whole-body therapeutic hypothermia for hypoxic-ischemic encephalopathy, a cohort study. Early Hum Dev. 2014 May;90(5):247–252.
   PubMed Web of Science ®Google Scholar
• van Wincoop M, de Bijl-Marcus K, Lilien M, et al. Effect of therapeutic hypothermia on renal and myocardial function in asphyxiated (near) term neonates: A systematic review and meta-analysis. Plos One. 2021;16(2):e0247403. doi: 10.1371/journal.pone.0247403
   PubMed Web of Science ®Google Scholar
• Allegaert K, Salaets T, Ward RM, et al. Qtc intervals are prolonged in late preterm and term neonates during therapeutic hypothermia but normalize afterwards. Children (Basel). 2021 Dec 8;8(12):1153.
   PubMed Web of Science ®Google Scholar
• Keles E, Wintermark P, Groenendaal F, et al. Serum creatinine patterns in neonates treated with therapeutic hypothermia for neonatal encephalopathy. Neonatology. 2022;119(6):686–694. doi: 10.1159/000525574
   PubMed Web of Science ®Google Scholar
• Krzyzanski W, Smits A, Van Den Anker J, et al. Population model of serum creatinine as time-dependent covariate in neonates. Aaps J. 2021 Jun 17;23(4):86.
   PubMed Web of Science ®Google Scholar
• Brucknerová I, Ujházy E, Dubovický M, et al. Early assessment of the severity of asphyxia in term newborns using parameters of blood count. Interdiscip Toxicol. 2008 Dec;1(3–4):211–213.
   PubMedGoogle Scholar
• Muniraman H, Gardner D, Skinner J, et al. Biomarkers of hepatic injury and function in neonatal hypoxic ischemic encephalopathy and with therapeutic hypothermia. Eur J Pediatr. 2017 Oct;176(10):1295–1303.
   PubMed Web of Science ®Google Scholar
• Groenendaal F, De Vooght KM, van Bel F. Blood gas values during hypothermia in asphyxiated term neonates. Pediatrics. 2009 Jan;123(1):170–172. doi: 10.1542/peds.2008-1955
   PubMed Web of Science ®Google Scholar
• Van Anh TN, Hao TK, Chi NTD, et al. Predictions of hypoxic-ischemic encephalopathy by umbilical cord blood lactate in newborns with birth asphyxia. Open Access Maced J Med Sci. 2019;7(21):3564–3567. doi: 10.3889/oamjms.2019.581
   PubMedGoogle Scholar
• Beach RC, Menzies IS, Clayden GS, et al. Gastrointestinal permeability changes in the preterm neonate. Arch Dis Child. 1982 Feb;57(2):141–145.
   PubMed Web of Science ®Google Scholar
• Hermans T, Carkeek K, Dereymaeker A, et al. Assessing neurovascular coupling using wavelet coherence in neonates with asphyxia. Adv Exp Med Biol. 2022;1395:183–187.
   PubMedGoogle Scholar
• Zhou KQ, McDouall A, Drury PP, et al. Treating Seizures after hypoxic-ischemic encephalopathy—Current controversies and future directions. IJMS. 2021 Jul 1;22(13):7121.
   Google Scholar
• Gebauer CM, Knuepfer M, Robel-Tillig E, et al. Hemodynamics among neonates with hypoxic-ischemic encephalopathy during whole-body hypothermia and passive rewarming. Pediatrics. 2006 Mar;117(3):843–850.
   PubMed Web of Science ®Google Scholar
• Sehgal A, Wong F, Mehta S. Reduced cardiac output and its correlation with coronary blood flow and troponin in asphyxiated infants treated with therapeutic hypothermia. Eur J Pediatr. 2012 Oct;171(10):1511–1517. doi: 10.1007/s00431-012-1764-y
   PubMed Web of Science ®Google Scholar
• Sakhuja P, More K, Ting JY, et al. Gastrointestinal hemodynamic changes during therapeutic hypothermia and after rewarming in neonatal hypoxic-Ischemic encephalopathy. Pediatr Neonatol. 2019 Dec;60(6):669–675.
   PubMed Web of Science ®Google Scholar
• Favié LMA, Groenendaal F, van den Broek MPH, et al. Phenobarbital, midazolam pharmacokinetics, effectiveness, and drug-drug interaction in asphyxiated neonates undergoing therapeutic hypothermia. Neonatology. 2019;116(2):154–162. doi: 10.1159/000499330
   PubMed Web of Science ®Google Scholar
• Favié LMA, de Haan TR, Bijleveld YA, et al. Prediction of drug exposure in critically Ill encephalopathic neonates treated with therapeutic hypothermia based on a pooled population pharmacokinetic analysis of seven drugs and five metabolites. Clin Pharmacol Ther. 2020 Nov;108(5):1098–1106. doi: 10.1002/cpt.1917
   PubMed Web of Science ®Google Scholar
• Allegaert K, van den Anker J. Dose-related adverse drug events in neonates: Recognition and assessment. J Clin Pharmacol. 2021 Jun;61(Suppl 1):S152–s160. doi: 10.1002/jcph.1827
   PubMedGoogle Scholar
• Dani C, Poggi C, Fancelli C, et al. Changes in bilirubin in infants with hypoxic-ischemic encephalopathy. Eur J Pediatr. 2018 Dec;177(12):1795–1801.
   PubMed Web of Science ®Google Scholar
• Annink KV, Franz AR, Derks JB, et al. Allopurinol: Old drug, new indication in neonates? Curr Pharm Des. 2017;23(38):5935–5942. doi: 10.2174/1381612823666170918123307
   PubMed Web of Science ®Google Scholar
• Maiwald CA, Annink KV, Rüdiger M, et al. Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III). BMC Pediatr. 2019 Jun 27;19(1):210.
   PubMedGoogle Scholar
• Favié LMA, Peeters-Scholte C, Bakker A, et al. Pharmacokinetics and short-term safety of the selective NOS inhibitor 2-iminobiotin in asphyxiated neonates treated with therapeutic hypothermia. Pediatr Res. 2020 Mar;87(4):689–696.
   PubMed Web of Science ®Google Scholar
• Wu YW, Comstock BA, Gonzalez FF, et al. Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns. N Engl J Med. 2022 Jul 14;387(2):148–159.
   PubMed Web of Science ®Google Scholar
• Allen KA, Brandon DH. Hypoxic ischemic encephalopathy: Pathophysiology and experimental treatments. Newborn Infant Nurs Rev. 2011 Sep 1;11(3):125–133.
   PubMedGoogle Scholar
• Yenari MA, Han HS. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci. 2012 Feb 22;13(4):267–278.
   PubMed Web of Science ®Google Scholar
• Kurisu K, Kim JY, You J, et al. Therapeutic hypothermia and neuroprotection in acute neurological disease. Curr Med Chem. 2019;26(29):5430–5455. doi: 10.2174/0929867326666190506124836
   PubMed Web of Science ®Google Scholar
• Jin JS, Sakaeda T, Kakumoto M, et al. Effect of therapeutic moderate hypothermia on multi-drug resistance protein 1-mediated transepithelial transport of drugs. Neurol Med Chir (Tokyo). 2006 Jul;46(7):321–327. discussion 327. doi: 10.2176/nmc.46.321
   PubMed Web of Science ®Google Scholar
• Kamme F, Campbell K, Wieloch T. Biphasic expression of the fos and jun families of transcription factors following transient forebrain ischaemia in the rat. Effect of hypothermia. Eur J Neurosci. 1995 Oct 1;7(10):2007–2016.
   PubMed Web of Science ®Google Scholar
• Akaji K, Suga S, Fujino T, et al. Effect of intra-ischemic hypothermia on the expression of c-Fos and c-Jun, and DNA binding activity of AP-1 after focal cerebral ischemia in rat brain. Brain Res. 2003 Jun 13;975(1–2):149–157.
   PubMed Web of Science ®Google Scholar
• Kobayashi MS, Asai S, Ishikawa K, et al. Global profiling of influence of intra-ischemic brain temperature on gene expression in rat brain. Brain Res Rev. 2008 Jun;58(1):171–191.
   PubMedGoogle Scholar
• Vemuganti R. The MicroRNAs and Stroke: No need to be coded to be counted. Transl Stroke Res. 2010 Sep 1;1(3):158–160.
   PubMed Web of Science ®Google Scholar
• Truettner JS, Alonso OF, Bramlett HM, et al. Therapeutic hypothermia alters microRNA responses to traumatic brain injury in rats. J Cereb Blood Flow Metab. 2011 Sep;31(9):1897–1907.
   PubMed Web of Science ®Google Scholar
• Looney AM, Walsh BH, Moloney G, et al. Downregulation of umbilical cord blood levels of miR-374a in neonatal hypoxic ischemic encephalopathy. J Pediatr. 2015 Aug;167(2):269–73.e2.
   PubMed Web of Science ®Google Scholar
• Winkler I, Heisinger T, Hammerl M, et al. MicroRNA expression profiles as diagnostic and prognostic biomarkers of perinatal asphyxia and hypoxic-ischaemic encephalopathy. Neonatology. 2022;119(2):204–213. doi: 10.1159/000521356
   PubMed Web of Science ®Google Scholar
• O’Sullivan MP, Looney AM, Moloney GM, et al. Validation of altered umbilical cord blood MicroRNA expression in neonatal hypoxic-ischemic encephalopathy. JAMA Neurol. 2019 Mar 1;76(3):333–341.
   PubMed Web of Science ®Google Scholar
• Fujita J. Cold shock response in mammalian cells. J Mol Microbiol Biotechnol. 1999 Nov;1(2):243–255.
   PubMedGoogle Scholar
• Sonna LA, Fujita J, Gaffin SL, et al. Invited review: Effects of heat and cold stress on mammalian gene expression. J Appl Physiol. 1985 Apr;92(4):1725–1742.
   Google Scholar
• Seo YM, Hwang-Bo S, Im SA, et al. Predictive value of heat-shock protein gene expression on severe neonatal hypoxic-ischemic encephalopathy. Diagnostics. 2022 Apr 13;12(4):981.
   Web of Science ®Google Scholar
• Oh JS, Park J, Kim K, et al. HSP70-mediated neuroprotection by combined treatment of valproic acid with hypothermia in a rat asphyxial cardiac arrest model. Plos One. 2021;16(6):e0253328. doi: 10.1371/journal.pone.0253328
   PubMed Web of Science ®Google Scholar
• Matz JM, Blake MJ, Tatelman HM, et al. Characterization and regulation of cold-induced heat shock protein expression in mouse brown adipose tissue. Am J Physiol. 1995 Jul;269(1 Pt 2):R38–47.
   PubMed Web of Science ®Google Scholar
• Kumar K, Wu X, Evans AT, et al. The effect of hypothermia on induction of heat shock protein (HSP)-72 in ischemic brain. Metab Brain Dis. 1995 Dec;10(4):283–291.
   PubMed Web of Science ®Google Scholar
• Lindquist JA, Mertens PR. Cold shock proteins: from cellular mechanisms to pathophysiology and disease. Cell Commun Signal. 2018 Sep 26;16(1):63.
   PubMedGoogle Scholar
• Heinemann U, Roske Y. Cold-shock domains—Abundance, structure, properties, and nucleic-acid binding. Cancers (Basel). 2021 Jan 7;13(2):190.
   PubMed Web of Science ®Google Scholar
• Alam HB, Hashmi S, Frankelstein RA, et al. Alterations in gene expression after induction of profound hypothermia for the treatment of lethal hemorrhage. J Trauma Acute Care Surg. 2010;68(5):1084–1098. doi: 10.1097/TA.0b013e3181d76bd1
   Google Scholar
• Patel J, McLeod LE, Vries RG, et al. Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors. Eur J Biochem. 2002 Jun;269(12):3076–3085.
   PubMedGoogle Scholar
• Hu BR, Wieloch T. Stress-induced inhibition of protein synthesis initiation: modulation of initiation factor 2 and guanine nucleotide exchange factor activities following transient cerebral ischemia in the rat. J Neurosci. 1993 May;13(5):1830–1838. doi: 10.1523/JNEUROSCI.13-05-01830.1993
   PubMed Web of Science ®Google Scholar
• Sonna LA, Kuhlmeier MM, Carter HC, et al. Effect of moderate hypothermia on gene expression by THP-1 cells: a DNA microarray study. Physiol Genomics. 2006 Jun 16;26(1):91–98.
   PubMed Web of Science ®Google Scholar
• Zak RB, Shute RJ, Heesch MW, et al. Impact of hot and cold exposure on human skeletal muscle gene expression. Appl Physiol Nutr Metab. 2017 Mar;42(3):319–325.
   PubMed Web of Science ®Google Scholar
• Faraji S, Rashki Ghaleno L, Sharafi M, et al. Gene expression alteration of sperm-Associated antigens in human cryopreserved sperm. Biopreserv Biobank. 2021 Dec;19(6):503–510.
   PubMed Web of Science ®Google Scholar
• Shaw L, Sneddon SF, Brison DR, et al. Comparison of gene expression in fresh and frozen-thawed human preimplantation embryos. Reproduction. 2012 Nov;144(5):569–582.
   PubMed Web of Science ®Google Scholar
• Tabuchi Y, Furusawa Y, Kariya A, et al. Common gene expression patterns responsive to mild temperature hyperthermia in normal human fibroblastic cells. Int J Hyperthermia. 2013;29(1):38–50. doi: 10.3109/02656736.2012.753163
   PubMed Web of Science ®Google Scholar
• Ito A, Aoyama T, Iijima H, et al. Culture temperature affects redifferentiation and cartilaginous extracellular matrix formation in dedifferentiated human chondrocytes. J Orthop Res. 2015 May;33(5):633–639.
   PubMed Web of Science ®Google Scholar
• Farashi S, Sharifi E. Stem cell behavior at hypothermia: A review article. Curr Stem Cell Res Ther. 2021;16(6):718–729. doi: 10.2174/1574888X16666201229124842
   PubMed Web of Science ®Google Scholar
• Fairchild KD, Singh IS, Carter HC, et al. Hypothermia enhances phosphorylation of I{kappa}B kinase and prolongs nuclear localization of NF-{kappa}B in lipopolysaccharide-activated macrophages. Am J Physiol Cell Physiol. 2005 Nov;289(5):C1114–21.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Kusakari S, Sato-Hashimoto M, et al. Hypothermia-induced tyrosine phosphorylation of SIRPα in the brain. J Neurochem. 2012;121(6):891–902. doi: 10.1111/j.1471-4159.2012.07748.x
   PubMed Web of Science ®Google Scholar
• Bretteville A, Marcouiller F, Julien C, et al. Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors. Sci Rep. 2012;2(1):480. doi: 10.1038/srep00480
   PubMedGoogle Scholar
• Zhao S, Xiao P, Cui H, et al. Hypothermia-induced ubiquitination of voltage-dependent anion channel 3 protects BV2 microglia cells from cytotoxicity following oxygen-glucose deprivation/recovery. Front Mol Neurosci. 2020;13:100. doi: 10.3389/fnmol.2020.00100
   PubMed Web of Science ®Google Scholar
• Bogert NV, Werner I, Kornberger A, et al. Influence of hypothermia and subsequent rewarming upon leukocyte-endothelial interactions and expression of Junctional-Adhesion-Molecules a and B. Sci Rep. 2016 Feb 25;6(1):21996.
   PubMedGoogle Scholar
• Yenari MA, Han HS. Influence of hypothermia on post-ischemic inflammation: role of nuclear factor kappa B (NFkappaB). Neurochem Int. 2006 Jul;49(2):164–169. doi: 10.1016/j.neuint.2006.03.016
   PubMed Web of Science ®Google Scholar
• Fairchild KD, Singh IS, Patel S, et al. Hypothermia prolongs activation of NF-kappaB and augments generation of inflammatory cytokines. Am J Physiol Cell Physiol. 2004 Aug;287(2):C422–31.
   PubMed Web of Science ®Google Scholar
• Shan Q, Ma F, Wei J, et al. Physiological functions of heat shock proteins. Curr Protein Pept Sci. 2020;21(8):751–760. doi: 10.2174/1389203720666191111113726
   PubMed Web of Science ®Google Scholar
• Maffucci I, Laage D, Sterpone F, et al. Thermal adaptation of enzymes: Impacts of conformational shifts on catalytic activation energy and optimum temperature. Chemistry. 2020 Aug 6;26(44):10045–10056.
   PubMed Web of Science ®Google Scholar
• Somero G. Temperature and proteins: Little things can mean a lot. Physiology. 1996;11(2):72–77. doi: 10.1152/physiologyonline.1996.11.2.72
   Google Scholar
• Davidovic M, Mattea C, Qvist J, et al. Protein cold denaturation as seen from the solvent. J Am Chem Soc. 2009 Jan 28;131(3):1025–1036.
   PubMed Web of Science ®Google Scholar
• Almeida VM, Marana SR, Lau ATY. Optimum temperature may be a misleading parameter in enzyme characterization and application. Plos One. 2019;14(2):e0212977. doi: 10.1371/journal.pone.0212977
   PubMed Web of Science ®Google Scholar
• Arcus VL, Prentice EJ, Hobbs JK, et al. On the temperature dependence of enzyme-catalyzed rates. Biochemistry. 2016 Mar 29;55(12):1681–1688.
   PubMed Web of Science ®Google Scholar
• Wojcik M, Miłek J. A new method to determine optimum temperature and activation energies for enzymatic reactions. Bioprocess Biosyst Eng. 2016 Aug;39(8):1319–1323. doi: 10.1007/s00449-016-1596-7
   PubMed Web of Science ®Google Scholar
• Manikandan P, Nagini S. Cytochrome P450 structure, function and clinical significance: A review. Curr Drug Targets. 2018;19(1):38–54. doi: 10.2174/1389450118666170125144557
   PubMed Web of Science ®Google Scholar
• Otyepka M, Skopalík J, Anzenbacherová E, et al. What common structural features and variations of mammalian P450s are known to date? Biochim Biophys Acta. 2007 Mar;1770(3):376–389.
   PubMed Web of Science ®Google Scholar
• Tilton RF Jr., Dewan JC, Petsko GA. Effects of temperature on protein structure and dynamics: X-ray crystallographic studies of the protein ribonuclease-A at nine different temperatures from 98 to 320 K. Biochemistry. 1992 Mar 10;31(9):2469–2481.
   PubMed Web of Science ®Google Scholar
• Zhou J, Poloyac SM. The effect of therapeutic hypothermia on drug metabolism and response: cellular mechanisms to organ function. Expert Opin Drug Metab Toxicol. 2011 Jul;7(7):803–816. doi: 10.1517/17425255.2011.574127
   PubMed Web of Science ®Google Scholar
• Somero GN. Proteins and temperature. Annu Rev Physiol. 1995;57(1):43–68. doi: 10.1146/annurev.ph.57.030195.000355
   PubMedGoogle Scholar
• Cojocaru V, Winn PJ, Wade RC. The ins and outs of cytochrome P450s. Biochim Biophys Acta. 2007 Mar;1770(3):390–401. doi: 10.1016/j.bbagen.2006.07.005
   PubMed Web of Science ®Google Scholar
• Diaz D, Fabre I, Daujat M, et al. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology. 1990 Sep;99(3):737–747.
   PubMed Web of Science ®Google Scholar
• Renwick AB, Watts PS, Edwards RJ, et al. Differential maintenance of cytochrome P450 enzymes in cultured precision-cut human liver slices. Drug Metab Dispos. 2000 Oct;28(10):1202–1209.
   PubMed Web of Science ®Google Scholar
• Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther. 2004 Aug;76(2):178–184. doi: 10.1016/j.clpt.2004.04.003
   PubMed Web of Science ®Google Scholar
• Magnusson MO, Dahl ML, Cederberg J, et al. Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin. Clin Pharmacol Ther. 2008 Jul;84(1):52–62.
   PubMed Web of Science ®Google Scholar
• Liston HL, DeVane CL, Boulton DW, et al. Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers. J Clin Psychopharmacol. 2002 Apr;22(2):169–173.
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan K, Obach RS. In vitro-in vivo extrapolation of CYP2D6 inactivation by paroxetine: prediction of nonstationary pharmacokinetics and drug interaction magnitude. Drug Metab Dispos. 2005 Jun;33(6):845–852. doi: 10.1124/dmd.105.004077
   PubMed Web of Science ®Google Scholar
• Lucas D, Ménez C, Girre C, et al. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcohol Clin Exp Res. 1995 Apr;19(2):362–366.
   PubMed Web of Science ®Google Scholar
• Emery MG, Jubert C, Thummel KE, et al. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans. J Pharmacol Exp Ther. 1999 Oct;291(1):213–219.
   PubMed Web of Science ®Google Scholar
• Pichard L, Fabre I, Daujat M, et al. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin a oxidase activity in primary cultures of human hepatocytes. Mol Pharmacol. 1992 Jun;41(6):1047–1055.
   PubMed Web of Science ®Google Scholar
• Levy RH, Pitlick WH, Troupin AS, and Green JR. The Effects of Disease States on Drug Pharmacokinetics. In: Benet, L. ed. Academy of Pharmaceutical Sciences. Washington DC; 1976. pp. 87-95.
   Google Scholar
• Lai AA, Levy RH, Cutler RE. Time-course of interaction between carbamazepine and clonazepam in normal man. Clin Pharmacol Ther. 1978 Sep;24(3):316–323. doi: 10.1002/cpt1978243316
   PubMed Web of Science ®Google Scholar
• Warren JW Jr., Benmaman JD, Wannamaker BB, et al. Kinetics of a carbamazepine-ethosuximide interaction. Clin Pharmacol Ther. 1980 Nov;28(5):646–651.
   PubMed Web of Science ®Google Scholar
• Fromm MF, Busse D, Kroemer HK, et al. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin. Hepatology. 1996 Oct;24(4):796–801.
   PubMed Web of Science ®Google Scholar
• Rostami-Hodjegan A, Wolff K, Hay AW, et al. Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes. Br J Clin Pharmacol. 1999 Jul;48(1):43–52.
   PubMed Web of Science ®Google Scholar
• Hsu A, Granneman GR, Witt G, et al. Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects. Antimicrob Agents Chemother. 1997 May;41(5):898–905.
   PubMed Web of Science ®Google Scholar
• von Bahr C, Steiner E, Koike Y, et al. Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism. Clin Pharmacol Ther. 1998 Jul;64(1):18–26.
   PubMed Web of Science ®Google Scholar
• Yang J, Liao M, Shou M, et al. Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions. Curr Drug Metab. 2008 Jun;9(5):384–394. doi: 10.2174/138920008784746382
   PubMed Web of Science ®Google Scholar
• van Groen BD, Nicolaï J, Kuik AC, et al. Ontogeny of hepatic transporters and drug-metabolizing enzymes in humans and in nonclinical species. Pharmacol Rev. 2021 Apr;73(2):597–678.
   PubMed Web of Science ®Google Scholar
• Mužić T, Tounsi F, Madsen SB, et al. Melting transitions in biomembranes. Biochim Biophys Acta Biomembr. 2019 Nov 1;1861(11):183026. doi: 10.1016/j.bbamem.2019.07.014
   PubMed Web of Science ®Google Scholar
• Baylon JL, Lenov IL, Sligar SG, et al. Characterizing the membrane-bound state of cytochrome P450 3A4: structure, depth of insertion, and orientation. J Am Chem Soc. 2013 Jun 12;135(23):8542–8551. doi: 10.1021/ja4003525
   PubMed Web of Science ®Google Scholar
• Sinensky M. Homeoviscous adaptation–a homeostatic process that regulates the viscosity of membrane lipids in Escherichia coli. Proc Natl Acad Sci U S A. 1974 Feb;71(2):522–525. doi: 10.1073/pnas.71.2.522
   PubMed Web of Science ®Google Scholar
• Anderson RL, Minton KW, Li GC, et al. Temperature-induced homeoviscous adaptation of Chinese hamster ovary cells. Biochim Biophys Acta. 1981 Mar 6;641(2):334–348. doi: 10.1016/0005-2736(81)90490-9
   PubMedGoogle Scholar
• Macdonald AG. The homeoviscous theory of adaptation applied to excitable membranes: a critical evaluation. Biochim Biophys Acta. 1990 Oct 8;1031(3):291–310. doi: 10.1016/0304-4157(90)90014-4
   PubMedGoogle Scholar
• Sojcic Z, Toplak H, Zuehlke R, et al. Cultured human skin fibroblasts modify their plasma membrane lipid composition and fluidity according to growth temperature suggesting homeoviscous adaptation at hypothermic (30 degrees C) but not at hyperthermic (40 degrees C) temperatures. Biochim Biophys Acta. 1992 Feb 17;1104(1):31–37. doi: 10.1016/0005-2736(92)90128-9
   PubMedGoogle Scholar
• Chalak L, Hellstrom-Westas L, Bonifacio S, et al. Bedside and laboratory neuromonitoring in neonatal encephalopathy. Semin Fetal Neonatal Med. 2021 Oct;26(5):101273.
   PubMed Web of Science ®Google Scholar
• Wisnowski JL, Wintermark P, Bonifacio SL, et al. Neuroimaging in the term newborn with neonatal encephalopathy. Semin Fetal Neonatal Med. 2021 Oct;26(5):101304.
   PubMed Web of Science ®Google Scholar
• Victor S, Rocha-Ferreira E, Rahim A, et al. New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy. Eur J Pediatr. 2022 Mar;181(3):875–887.
   PubMed Web of Science ®Google Scholar
• Lutz IC, Allegaert K, de Hoon JN, et al. Pharmacokinetics during therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy: a literature review. BMJ Paediatr Open. 2020;4(1):e000685. doi: 10.1136/bmjpo-2020-000685
   PubMedGoogle Scholar
• Deferm N, Annink KV, Faelens R, et al. Glomerular filtration rate in asphyxiated neonates under therapeutic whole-body hypothermia, quantified by mannitol clearance. Clin Pharmacokinet. 2021 Jul;60(7):897–906.
   PubMed Web of Science ®Google Scholar
• Cristea S, Smits A, Kulo A, et al. Amikacin pharmacokinetics to optimize dosing in neonates with perinatal asphyxia treated with hypothermia. Antimicrob Agents Chemother. 2017 Dec;61(12). doi: 10.1128/AAC.01282-17
   PubMed Web of Science ®Google Scholar
• Bijleveld YA, de Haan TR, van der Lee HJ, et al. Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia. Br J Clin Pharmacol. 2016 Jun;81(6):1067–1077.
   PubMed Web of Science ®Google Scholar
• Frymoyer A, Lee S, Bonifacio SL, et al. Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. J Perinatol. 2013 Oct;33(10):778–782.
   PubMed Web of Science ®Google Scholar
• Smits A, Annaert P, Van Cruchten S, et al. A physiology-based pharmacokinetic framework to support drug development and dose precision during therapeutic hypothermia in neonates [Review]. Front Pharmacol. 2020 2020 May 13; 11:11. doi: 10.3389/fphar.2020.00587
   PubMed Web of Science ®Google Scholar
• Weerink MAS, Struys M, Hannivoort LN, et al. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017 Aug;56(8):893–913.
   PubMed Web of Science ®Google Scholar
• O’Mara K, Weiss MD. Dexmedetomidine for sedation of neonates with HIE undergoing therapeutic hypothermia: A single-center experience. AJP Rep. 2018 Jul;8(3):e168–e173. doi: 10.1055/s-0038-1669938
   PubMed Web of Science ®Google Scholar
• Elliott M, Burnsed J, Heinan K, et al. Effect of dexmedetomidine on heart rate in neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia. J Neonatal Perinatal Med. 2022;15(1):47–54. doi: 10.3233/NPM-210737
   PubMedGoogle Scholar
• McAdams RM, Pak D, Lalovic B, et al. Dexmedetomidine pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. Anesthesiol Res Pract. 2020;2020:1–15. doi: 10.1155/2020/2582965
   Web of Science ®Google Scholar
• Naveed M, Bondi DS, Shah PA. Dexmedetomidine versus fentanyl for neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia. J Pediatr Pharmacol Ther. 2022;27(4):352–357. doi: 10.5863/1551-6776-27.4.352
   PubMedGoogle Scholar
• Bäcke P, Bruschettini M, Sibrecht G, et al. Pharmacological interventions for pain and sedation management in newborn infants undergoing therapeutic hypothermia. Cochrane Database Syst Rev. 2022 Nov 10;11(11):Cd015023.
   PubMedGoogle Scholar
• Baserga M, DuPont TL, Ostrander B, et al. Dexmedetomidine use in infants undergoing cooling due to neonatal encephalopathy (DICE Trial): A randomized controlled trial: Background, aims and study protocol. Front Pain Res (Lausanne). 2021;2:770511. doi: 10.3389/fpain.2021.770511
   PubMedGoogle Scholar
• Ayuso M, Buyssens L, Stroe M, et al. The neonatal and juvenile pig in pediatric drug discovery and development. Pharmaceutics. 2021;13(1):44. doi: 10.3390/pharmaceutics13010044
   Web of Science ®Google Scholar
• Mallard C, Vexler ZS. Modeling ischemia in the immature brain. Stroke. 2015;46(10):3006–3011. doi: 10.1161/STROKEAHA.115.007776
   PubMed Web of Science ®Google Scholar
• van Dijk AJ, van Loon JPAM, Taverne MAM, et al. Umbilical cord clamping in term piglets: A useful model to study perinatal asphyxia? Theriogenology. 2008 2008 Sep 1;70(4):662–674. doi: 10.1016/j.theriogenology.2008.04.044
   PubMed Web of Science ®Google Scholar
• Cheung P-Y, Gill RS, Bigam DL. A swine model of neonatal asphyxia. J Vis Exp. 2011;56(56):3166. doi: 10.3791/3166-v
   Google Scholar
• O’Brien CE, Santos PT, Kulikowicz E, et al. Hypoxia-ischemia and hypothermia independently and interactively affect neuronal pathology in neonatal piglets with short-term recovery. Dev Neurosci. 2019;41(1–2):17–33. doi: 10.1159/000496602
   PubMed Web of Science ®Google Scholar
• Kyng KJ, Skajaa T, Kerrn-Jespersen S, et al. A piglet model of neonatal hypoxic-ischemic encephalopathy. J Vis Exp. 2015;99(99):e52454–e52454. doi: 10.3791/52454
   Google Scholar
• Ezzati M, Broad K, Kawano G, et al. Pharmacokinetics of dexmedetomidine combined with therapeutic hypothermia in a piglet asphyxia model. Acta Anaesthesiol Scand. 2014 Jul;58(6):733–742.
   PubMed Web of Science ®Google Scholar
• Stroe M-S, Van Bockstal L, Valenzuela AP, et al. Development of a neonatal Göttingen minipig model for dose precision in perinatal asphyxia: technical opportunities, challenges, and potential further steps [Methods]. Front Pediatr. 2023;11:662.
   Web of Science ®Google Scholar
• Robertson NJ, Faulkner S, Fleiss B, et al. Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain. 2012;136(1):90–105. doi: 10.1093/brain/aws285
   PubMedGoogle Scholar
• Whitaker EE, Zheng CZ, Bissonnette B, et al. Use of a piglet model for the study of anesthetic-induced developmental neurotoxicity (AIDN): A translational neuroscience approach. J Vis Exp. 2017 Jun;11(124). doi: 10.3791/55193-v
   Google Scholar
• McMahon AW, Dal Pan G. Assessing drug safety in children - the role of real-world data. N Engl J Med. 2018 Jun 7;378(23):2155–2157.
   PubMed Web of Science ®Google Scholar
• Smits A, De Cock P, Vermeulen A, et al. Physiologically based pharmacokinetic (PBPK) modeling and simulation in neonatal drug development: how clinicians can contribute. Expert Opin Drug Metab Toxicol. 2019 Jan;15(1):25–34.
   PubMed Web of Science ®Google Scholar
• Wu YE, Wang T, Yang HL, et al. Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study. J Antimicrob Chemother. 2021 Feb 11;76(3):699–709.
   PubMed Web of Science ®Google Scholar
• Yamada T, Emoto C, Fukuda T, et al. Optimal teicoplanin dosing regimen in neonates and children developed by leveraging real-world clinical information. Ther Drug Monit. 2022 Jun 1;44(3):404–413.
   PubMed Web of Science ®Google Scholar
• Zhou W, Johnson TN, Xu H, et al. Predictive performance of physiologically based pharmacokinetic and population pharmacokinetic modeling of renally cleared drugs in children. CPT Pharmacometrics Syst Pharmacol. 2016 Sep;5(9):475–483. doi: 10.1002/psp4.12101
   PubMedGoogle Scholar
• Zhou W, Johnson TN, Bui KH, et al. Predictive performance of physiologically based pharmacokinetic (PBPK) modeling of drugs extensively metabolized by major cytochrome P450s in children. Clin Pharmacol Ther. 2018 Jul;104(1):188–200. doi: 10.1002/cpt.905
   PubMed Web of Science ®Google Scholar
• Dang A. Real-world evidence: A primer. Pharmaceut Med. 2023 Jan;37(1):25–36. doi: 10.1007/s40290-022-00456-6
   PubMed Web of Science ®Google Scholar
• Sawtell M, van Blankenstein E, Bilal T, et al. Views of parents, adults born preterm and professionals on linkage of real-world data of preterm babies. Arch Dis Child Fetal Neonatal Ed. 2022 Oct 19;108(2):194–199. doi: 10.1136/archdischild-2022-324272
   PubMed Web of Science ®Google Scholar
• Lin W, Chen Y, Unadkat JD, et al. Applications, challenges, and outlook for PBPK modeling and simulation: A regulatory, industrial and academic perspective. Pharm Res. 2022 Aug;39(8):1701–1731.
   PubMed Web of Science ®Google Scholar
• Loisios-Konstantinidis I, Dressman J. Physiologically based pharmacokinetic/pharmacodynamic modeling to support waivers of in vivo clinical studies: Current status, challenges, and opportunities. Mol Pharm. 2021 Jan 4;18(1):1–17.
   PubMedGoogle Scholar
• Kovar L, Weber A, Zemlin M, et al. Physiologically-based pharmacokinetic (PBPK) modeling providing insights into fentanyl pharmacokinetics in adults and pediatric patients. Pharmaceutics. 2020 Sep 23;12(10):908.
   PubMed Web of Science ®Google Scholar
• Maharaj AR, Barrett JS, Edginton AN. A workflow example of PBPK modeling to support pediatric research and development: Case study with lorazepam.Aaps J. 2013 2013 Apr 1;15(2):455–464. doi: 10.1208/s12248-013-9451-0
   PubMed Web of Science ®Google Scholar
• Hindmarsh DRR AC, Serban R, Woodward CS, et al. The open systems pharmacology suite: Lawrence Livermore national laboratory; 2002-2021 [cited Jan 2023]. 10.02.23 11 [ Available from: https://docs.open-systems-pharmacology.org
   Google Scholar
• Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89. Ann ICRP. 2002;32(3–4):5–265. doi: 10.1016/S0146-6453(03)00002-2
   PubMedGoogle Scholar
• Parrott N, Davies B, Hoffmann G, et al. Development of a physiologically based model for oseltamivir and simulation of pharmacokinetics in neonates and infants. Clin Pharmacokinet. 2011 Sep;50(9):613–623.
   PubMed Web of Science ®Google Scholar
• Leys K, Smits A, Allegaert K, et al. In vitro investigation of pharmacokinetics in neonates undergoing therapeutic hypothermia. In 50th Annual Conference of the European Teratology Society; 2022 25-28 Sep 2022; Antwerp, Belgium.
   Google Scholar
• Stroe M-S, Van Bockstal L, Valenzuela AP, et al., The neonatal Göttingen Minipig as translational model for drug disposition in perinatal asphyxia. In 50th Annual Conference of the European Teratology Society; 2022 25-28 Sep 2022; Antwerp, Belgium.
   Google Scholar
• Campion S, Inselman A, Hayes B, et al. The benefits, limitations and opportunities of preclinical models for neonatal drug development. Dis Model Mech. 2022 Apr 1;15(4). doi: 10.1242/dmm.049065
   PubMed Web of Science ®Google Scholar
• Rieger JK, Klein K, Winter S, et al. Expression variability of absorption, distribution, metabolism, excretion-related microRnas in human liver: influence of nongenetic factors and association with gene expression. Drug Metab Dispos. 2013 Oct;41(10):1752–1762.
   PubMed Web of Science ®Google Scholar
• McCaw BA, Stevenson TJ, Lancaster LT. Epigenetic responses to temperature and climate. Integr Comp Biol. 2020 Dec 16;60(6):1469–1480.
   PubMed Web of Science ®Google Scholar
• Wintermark P, Mohammad K, Bonifacio SL. Proposing a care practice bundle for neonatal encephalopathy during therapeutic hypothermia. Semin Fetal Neonatal Med. 2021 Oct;26(5):101303. doi: 10.1016/j.siny.2021.101303
   PubMed Web of Science ®Google Scholar
• Wojtyniak JG, Selzer D, Schwab M, et al. Physiologically based precision dosing approach for drug-drug-gene interactions: A simvastatin network analysis. Clin Pharmacol Ther. 2021 Jan;109(1):201–211.
   PubMed Web of Science ®Google Scholar
• Min JS, Bae SK. Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling. Arch Pharm Res. 2017 Dec;40(12):1356–1379. doi: 10.1007/s12272-017-0976-0
   PubMed Web of Science ®Google Scholar
• Croft NM, de Ridder L, Griffiths AM, et al. Paediatric inflammatory bowel disease: a multi-stakeholder perspective to improve development of drugs for children and adolescents. Journal Of Crohn’s And Colitis. 2022 Sep 21;17(2):249–258. doi: 10.1093/ecco-jcc/jjac135
   PubMed Web of Science ®Google Scholar
• Pearson ADJ, Weiner SL, Adamson PC, et al. ACCELERATE - Five years accelerating cancer drug development for children and adolescents. Eur J Cancer. 2022 May;166:145–164.
   PubMed Web of Science ®Google Scholar